EUVIMEDEUVIMED entdecken
LeserbriefVergleichsstudieOpen Access

BEAM versus pharmacokinetics‐directed BuCyVP16 conditioning for patients with peripheral T‐cell lymphoma undergoing high‐dose therapy with autologous hematopoietic cell transplantation

Robert Stuver iD, Agrima Mian, Samantha Brown iD, Sean Devlin, Paolo F Caimi, Stephanie Chinapen iD, Parastoo Dahi, Robert Dean, Zachary D Epstein-Peterson, Brian Hill, Steven M Horwitz, Oscar Lahoud iD und 7 weitere

American Journal of Hematology · 2024

DOI: 10.1002/ajh.27291 ↗

Kurz gefasst

Leserbrief in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Robert Stuver und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Lymphoma, T-Cell, Peripheral, Transplantation Conditioning, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationLymphoma, T-Cell, PeripheralTransplantation ConditioningAntineoplastic Combined Chemotherapy ProtocolsTransplantation, AutologousHumansMaleMiddle AgedFemaleCytarabineCarmustineAdultMelphalanAged

Substanzen

CytarabineCarmustineMelphalan

Autor:innen und Institutionen

  • Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Medicine, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID-Profile: Robert Stuver, Samantha Brown, Stephanie Chinapen, Oscar Lahoud, Alison Winter

Förderung

  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Stuver, R., Mian, A., Brown, S., Devlin, S., Caimi, P. F., Chinapen, S., Dahi, P., Dean, R., Epstein-Peterson, Z. D., Hill, B., Horwitz, S. M., Lahoud, O., Lin, R., Moskowitz, A. J., Sauter, C., Shah, G., Winter, A., Jagadeesh, D., & Scordo, M. (2024). BEAM versus pharmacokinetics‐directed BuCyVP16 conditioning for patients with peripheral T‐cell lymphoma undergoing high‐dose therapy with autologous hematopoietic cell transplantation. American Journal of Hematology. https://doi.org/10.1002/ajh.27291

Vancouver

Stuver R, Mian A, Brown S, Devlin S, Caimi PF, Chinapen S, et al. BEAM versus pharmacokinetics‐directed BuCyVP16 conditioning for patients with peripheral T‐cell lymphoma undergoing high‐dose therapy with autologous hematopoietic cell transplantation. American Journal of Hematology. 2024. doi:10.1002/ajh.27291

BibTeX
@article{Stuver2024,
  author = {Stuver, Robert and Mian, Agrima and Brown, Samantha and Devlin, Sean and Caimi, Paolo F and Chinapen, Stephanie and Dahi, Parastoo and Dean, Robert and Epstein-Peterson, Zachary D and Hill, Brian and Horwitz, Steven M and Lahoud, Oscar and Lin, Richard and Moskowitz, Alison J and Sauter, Craig and Shah, Gunjan and Winter, Alison and Jagadeesh, Deepa and Scordo, Michael},
  title = {BEAM versus pharmacokinetics‐directed BuCyVP16 conditioning for patients with peripheral T‐cell lymphoma undergoing high‐dose therapy with autologous hematopoietic cell transplantation},
  journal = {American Journal of Hematology},
  year = {2024},
  doi = {10.1002/ajh.27291}
}
Kostenlos starten →